Home›Companies›Biotech & Pharma›PharmassêtX

PharmassetX Inc.

Develops a drug for people with pouchitis and other chronic inflammatory diseases.

No LinkedIn page we could confirm. Why?
Updated Nov 10, 2026·Latest SEC filing May 4, 2026·Suggest an edit

About PharmassêtX

PharmassêtX is a private company based in Louisville, Kentucky, incorporated in 2024 in Delaware. It has reported $150,000 raised in two offerings on Form D since October 2025. Its chief executive is Terry Minton.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 30, 2026May 4, 2026$100,000of $6.0M target1$100KSimple Agreement for Future Equity (SAFE)Rule 506(b)Form D ↗
Sep 10, 2025Oct 10, 2025$50,000of $20.0M target1$50,000Simple Agreement for Future Equity (SAFE)Rule 506(b)Form D ↗
Total, two offerings$150,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on PharmassêtX's Form D filed May 4, 2026.

DM
David McClure
Chief Operating Officer and director
GD
Gerald Dryden
Chief Medical Officer and director
TM
Terry Minton
Chief Executive Officer and director

Sources

  1. SECPharmassetX Inc. filing history